Seer (SEER) Total Current Liabilities (2020 - 2026)
Seer (SEER) posted quarterly Total Current Liabilities of $10.2 million for Q1 2026, down 22.38% year-over-year from $13.2 million in Q1 2025, and down 34.72% quarter-over-quarter from $15.7 million in Q4 2025.
Seer (SEER) Total Current Liabilities (2020 - 2026) Analysis & Trends
Seer's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 22.38% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (down 22.38% YoY), while the FY2025 annual figure was $15.7 million, up 2.37% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $10.2 million, down from $15.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $17.0 million in Q2 2024, with the low at $10.2 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $13.2 million (2023), against an average of $13.6 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 79.82% in 2022, then tumbled 30.83% in 2025.
- Seer's Total Current Liabilities stood at $12.6 million in 2022, then climbed by 5.07% to $13.2 million in 2023, then grew by 15.93% to $15.3 million in 2024, then gained by 2.37% to $15.7 million in 2025, then tumbled by 34.72% to $10.2 million in 2026.
- Business Quant data shows SEER's Total Current Liabilities at $10.2 million in Q1 2026, $15.7 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 11.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.27 Mn |
| Mar 31, 2026 | 10.24 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 15.04 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 13.20 Mn |
| Dec 31, 2024 | 15.33 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 17.04 Mn |
| Mar 31, 2024 | 12.83 Mn |
| Dec 31, 2023 | 13.22 Mn |
| Sep 30, 2023 | 12.52 Mn |
| Jun 30, 2023 | 15.81 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 12.58 Mn |
| Sep 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 15.02 Mn |
| Mar 31, 2022 | 11.15 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 9.55 Mn |